Allpack Deliver Festive Cheer To QE

4th January 2021


After such a challenging 2020 for clinical staff across the country, Midlands-based packaging firm Allpack spread some festive cheer by donating gift hampers to patients and staff at Birmingham's Queen Elizabeth Hospital on Christmas Eve morning. 

Upon delivering Christmas gifts to the QE and The Centre for Clinical Haematology, Allpack managing director, George Clarke, met with department staff to thank them for their continued service in providing world class treatment and care. 

Senior Sister at the QE Kimberley Macken commented:

"Staff working on the Haematology inpatient wards at the Queen Elizabeth Hospital were extremely grateful for the donations of the hampers. 2020 has been a very challenging year for us all! It’s the little things like this that help let the staff know that they are appreciated and add a little bit of festive cheer in the middle of the COVID pandemic."

The hospital's haemotology centre, built in 2005 and expanded in 2017 thanks to an additional £1m in funding from Cure Leukaemia, is a leading research hub, delivering drug treatments and transplant therapies to patients with blood cancer. 

Cure Leukaemia CEO James McLaughlin said:

"2020 was such a difficult year for us all but even moreso for clinicians and patients across the UK and that continues to be the case as we enter 2021. We are so grateful to Allpack for this incredibly generous gesture which I am sure was welcomed by staff and patients here in Birmingham."

 

< Back to List

What we do

The Trials Acceleration Programme (TAP)

How funds raised for Cure Leukaemia help save lives

Cure Leukamia Pre footer image
"Cure Leukaemia’s funding of the UK Trials Acceleration Programme (TAP) is a game-changer and increases the access for blood cancer patients to potentially transformative new therapies."

Sir John Bell
"Cure Leukaemia’s funding of the UK Trials Acceleration Programme (TAP) is a game-changer and increases the access for blood cancer patients to potentially transformative new therapies."

Sir John Bell